Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Dermatologic 2

Conditions

Hodgkin Disease 5Lymphoma 4Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Recurrence 1Dermatitis, Contact 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

fludarabine phosphate 17Mycophenolic Acid 17Tacrolimus 15Peripheral Blood Stem Cell Transplantation 14Whole-Body Irradiation 13Cyclophosphamide 12Methotrexate 10Cyclosporine 10Busulfan 9Antilymphocyte Serum 9Radiotherapy 7pembrolizumab 5Methylprednisolone 5Bexarotene 5Alemtuzumab 5merphos 4Vorinostat 4Transplantation 4Rituximab 4Melphalan 4Flow Cytometry 4Cord Blood Stem Cell Transplantation 4Brentuximab Vedotin 4Amines 4sargramostim 3mogamulizumab 3hypericin 3Therapeutics 3Sirolimus 3Panobinostat 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Mycosis Fungoides × Mechlorethamine × Clear all
NCT03380026 2021-11-24

MIDAS

Rochester Skin Lymphoma Medical Group, PLLC

Phase 2 Completed
28 enrolled 8 charts
DermatologicLymphoid

Dermatitis, Contact, Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

NCT00168064 2012-10-31

Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides

Yaupon Therapeutics

Phase 2 Completed
260 enrolled 8 charts
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡